13h
Zacks.com on MSNShould Edwards Lifesciences Stock Remain in Your Portfolio Now?Edwards Lifesciences’ EW fourth-quarter performance was backed by its most comprehensive structural heart disease portfolio. The Surgical Structural Heart business is benefiting from the strong ...
During the fourth quarter, the Harbor Capital Appreciation Fund returned 6.22%, underperforming its benchmark, the Russell ...
It’s Heart Health Month and we’re discussing what you need to know about a potentially lifesaving approach to treat a heart ...
Researchers have identified a gene therapy that could prevent life-threatening arrhythmias by restoring the heart’s ...
Amanda Edwards/Getty Images Hayden Panettiere is still mourning the death of her younger brother, Jansen Panettiere. "Two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results